Partners of the National Cancer Research Institute reported a total spend in 2016 / 2017 of over £683.3million on research, just 0.06% of this was directed specifically to primary bone cancer.
These latest figures indicate that overall research investment has increased by 16% compared to the previous year, however, research directed specifically to primary bone cancer dropped by 3% to just £431,654. Partners of the National Cancer Research Institute include: Cancer Research UK, Department of Health & Social Care, Wellcome Trust, Marie Curie, Macmillan Cancer Support and the Public Health Agency amongst others.
Of these latest figures our Head of Research & Information, Dr Zoe Davison, said:
We are disappointed to see this reduction from the NCRI Partners. We will continue to try and work with other organisations to influence increased spend on primary bone cancer research. It is only through increased investment that we will start to see increases in survival rates, which for primary bone cancer patients have remained largely unchanged for 30 years. Increased investment in recent years into the more common forms of cancer has led to significant improvements in survival and quality of life for patients. By the end of 2018 the Bone Cancer Research Trust will have committed a further £1,215,437 to our own Grant Programme and will continue to fuel as much research as our resources will allow.
Thanks to our supporters, since being founded in 2006, the Bone Cancer Research Trust has funded over 100 researchers and 65 research projects into primary bone cancer totalling over £3.5million. This figure will rise to over £4.5million committed by the end of 2018.
To support research being funded by the Bone Cancer Research Trust, become a Research Sponsor today and put 100% of your donation into what you care about - saving lives and finding a cure for primary bone cancer.